T2‐Weighted MR Imaging‐Derived Radiomics for Pretreatment Determination of Therapeutic Response to Glucocorticoid in Patients With Thyroid‐Associated Ophthalmopathy: Comparison With Semiquantitative Evaluation

Background MR imaging has been applied to determine therapeutic response to glucocorticoid (GC) before treatment in thyroid‐associated ophthalmopathy (TAO), while the performance was still poor. Purpose To investigate the value of T2‐weighted imaging (T2WI)‐derived radiomics for pretreatment determination of therapeutic response to GC in TAO patients, and compare its diagnostic performance with that of semiquantitative parameters. Study Type Retrospective. Population A total of 110 patients (49 ± 12 years; male/female, n = 48/62; responsive/unresponsive, n = 62/48), divided into training (n = 78) and validation (n = 32) cohorts. Field Strength/Sequence 3.0 T, T2‐weighted fast spin echo. Assessment W.C. and H.H. (6 and 10 years of experience, respectively) performed the measurements. Maximum, mean, and minimum signal intensity ratios (SIRs) of extraocular muscle (EOM) bellies were collected to construct a semiquantitative imaging model. Radiomics features from volumes of interest covering EOM bellies were extracted and three machine learning‐based (logistic regression [LR]; decision tree [DT]; support vector machine [SVM]) models were built. Statistical Tests The diagnostic performances of models were evaluated using receiver operating characteristic curve analyses, and compared using DeLong test. Two‐sided P